Karuna Therapeutics
KRTX
$329.83
Share price
0.00%
Change (1 day)
67.86%
Change (1 year)
Categories
Karuna Therapeutics (KRTX) - P/B ratio
P/B ratio as of April 2024 : 10.0
According to Karuna Therapeutics's latest financial reports the company has a price-to-book ratio of 10.0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Karuna Therapeutics - P/B ratio (from 2019 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 9.56 | 59.5% |
| 2022-12-31 | 6.00 | -22.44% |
| 2021-12-31 | 7.73 | -3.79% |
| 2020-12-31 | 8.03 | 59.86% |
| 2019-12-31 | 5.03 | |
| 2018-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.43 | -75.82% | 🇺🇸 USA |